NARB Recommends Kimberly-Clark Discontinue Certain Claims Made for Huggies Following P&G Challenge

New York, NY – Feb. 6, 2019 – A panel of the National Advertising Review Board (NARB) has recommended that Kimberly-Clark discontinue its “fastest growing brand in hospitals” claim unless that claim is supported by recent data that includes Kimberly-Clark’s sales data in addition to reliable third-party sales or market share data for the hospital diaper market as a whole. The panel also recommended that any such claim be qualified to exclude smaller competitors that have grown at a faster rate (e.g., the “fastest growing brand” claim could indicate that it is being made against leading brands).

NARB is the appellate unit of the advertising industry’s system of self-regulation. It is administered by the Council of Better Business Bureaus.

The advertising at issue was challenged by The Procter & Gamble Company before the National Advertising Division (NAD), an investigative unit of the advertising industry’s system of self-regulation.

NAD recommended that the advertiser discontinue its claim that “Huggies® diapers is the fastest growing brand in hospitals (‘based on volume share growth.’)”

Kimberly-Clark appealed the NAD’s recommendation to NARB.

Kimberly-Clark’s support for its “fastest growing brand in hospitals” claim relied on a zero-sum analysis of the hospital diaper market between the second quarter of 2016 and the second quarter of 2017; it argued that due to declining birth rates and consistent procurement/use of diapers by hospitals, combined with the fact that Kimberly-Clark and Procter & Gamble accounted for 99.5% of the hospital diaper market, any increase in Kimberly-Clark’s diaper sales to hospitals necessarily resulted in a decrease in Procter & Gamble’s sales and thus an increase in Kimberly-Clark’s market share. Procter & Gamble disagreed with this analysis, arguing that the hospital diaper market was not fixed and Procter & Gamble’s sales in this market increased during the relevant time period.

The panel agreed with the NAD that support for a comparative “fastest growing brand” claim should include reliable sales or market share data for the market as a whole as collected and reported by a reliable third party. The panel further agreed with the NAD that the assumptions made by Kimberly-Clark with respect to the hospital diaper market were not sufficiently reliable to provide a reasonable basis for the claim made – there was insufficient evidence in the record that hospitals and hospital networks uniformly operate in a consistent manner in procuring diapers and/or providing diapers to hospital patients.

The panel noted that during the NAD proceeding Procter & Gamble supplied sales data that, in conjunction with Kimberly-Clark’s sales data, provided virtually complete sales data for the hospital diaper market between the second quarter of 2016 and the second quarter of 2017. When combined, the data from Procter & Gamble and Kimberly-Clark established that

Kimberly-Clark’s diaper sales to hospitals grew faster than Procter & Gamble’s during that time period. However, the panel found this data was too old to support a current “fastest growing brand in hospitals” claim, and that such a claim would need to be substantiated with more recent internal sales data in addition to reliable third-party sales or market share data for the hospital diaper market as a whole.

The panel recommended that Kimberly-Clark discontinue its “fastest growing brand in hospitals” claim unless that claim is supported by recent data that includes Kimberly-Clark’s sales data in addition to reliable third-party sales or market share data for the hospital diaper market as a whole. The panel also recommended that any such claim be qualified to exclude smaller competitors that have grown at a faster rate (e.g., the “fastest growing brand” claim could indicate that it is being made against leading brands).

Kimberly-Clark, in its advertiser’s statement, thanked the Panel and agreed to comply with the Panel’s recommendations in future advertising.  “While NARB found that this [sales] data is too old to support a current “Fastest Growing Brand in Hospitals” claim, K-C is gratified that NARB found that the claim was supported, with possible qualification as to smaller competitors, during the pendency of the NAD challenge,” Kimberly-Clark said.

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Recommends Blueprint Test Preparation Discontinue Certain MCAT Score Improvement Claims

New York, NY – April 22, 2024 – The National Advertising Division recommended Blueprint Test Preparation discontinue certain express and implied claims made in connection with its four MCAT preparation courses, including claims that Blueprint students raise their MCAT scores by 15 or 13 points on average.

Read the Decision Summary
Decision

National Advertising Division Recommends The Princeton Review Discontinue Point Increase Claims for MCAT Test Preparation Services

New York, NY – April 18, 2024 – In a Fast-Track SWIFT challenge, the National Advertising Division recommended that The Princeton Review (TPR) discontinue claims that its students “Score a 515+ on the MCAT or add 15 points depending on your starting score. Guaranteed or your money back.”

Read the Decision Summary
Decision

Direct Selling Self-Regulatory Council Recommends Trades of Hope Discontinue Salesforce Member Earnings Claims

McLean, VA – April 17, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended that Trades of Hope discontinue certain earnings claims made by salesforce members on Facebook and YouTube. 

Read the Decision Summary
Decision

National Advertising Division Recommends Lily of the Desert Nutraceuticals Discontinue “100% Pure Avocado Oil” Claim for Tropical Plantation Avocado Oil

New York, NY – April 15, 2024 – The National Advertising Division recommended that Lily of the Desert Nutraceuticals discontinue the claim “100% Pure Avocado Oil” for its Tropical Plantation Avocado Oil and avoid conveying the unsupported message that the product is 100% pure avocado...

Read the Decision Summary